Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
l arginine/rak
Veza se sprema u međuspremnik
10 rezultatima
Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention covers pharmaceutical compositions, and method for the treatment of cancer using substituted purinyl compounds. In particular, the present invention concerns 6-substituted purinyl alkoxycarbonyl amino acid compounds, more particularly arginine
Compositions of engineered human arginases and methods for treating cancer
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The sequence listing that is contained in the file named "GGEOP0002USC2_ST25.txt", which was created on Nov. 17, 2014, is filed herewith by electronic submission and is incorporated by reference herein.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention generally relates to
Compositions of engineered human arginases and methods for treating cancer
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention generally relates to compositions and methods for the treatment of cancer with enzymes that deplete L-Arginine in serum. In some embodiments, the cancer is one that does not express, or is otherwise deficient in, argininosuccinate
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention relates to, inter alia, a novel crystalline free-plate habit or morphology, processes for preparing the crystalline free-plate habit, and uses of the crystalline free-plate habit of the L-arginine salt of
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention relates to, inter alia, a novel crystalline free-plate habit or morphology, processes for preparing the crystalline free-plate habit, and uses of the crystalline free-plate habit of the L-arginine salt of
Polyion complex of poly(L-arginine) segment-containing block copolymer and polyanionic polymer
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD
The present invention relates to a polyion complex (PIC) containing poly(ethylene glycol)-b-poly(L-arginine) or poly(L-arginine)-b-poly(ethylene glycol)-b-poly(L-arginine) and a polyanionic polymer, application of the PIC such as use thereof for activation of macrophages in tumor
Inhibiting furin with polybasic peptides
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
This invention pertains to the inhibition of furin, which can be used in inhibiting certain bacterial infections, viral infections, and cancers.
Furin, a ubiquitous serine endoprotease, has been implicated in the activation of certain bacterial toxins and viral glycoproteins, as well as in the
Inhibiting furin with polybasic peptides
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
This invention pertains to the inhibition of furin, which can be used in inhibiting certain bacterial infections, viral infections, and cancers.
Furin, a ubiquitous serine endoprotease, has been implicated in the activation of certain bacterial toxins and viral glycoproteins, as well as in the
Formulations of Factor VIIa inhibitors and utility
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The field relates to the use of novel nanoparticle formulations and chemical structures that include vasodilator Factor VIIa inhibitors to treat vascular disorders in a subject.
BACKGROUND OF THE INVENTION
Vascular endothelial-mediated disorders including sickle cell diseases,
Diagnostic assay and treatment for preeclampsia
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
CROSS-REFERENCE TO RELATED APPLICATION
This application is a U.S. national entry application under 37 C.F.R. .sctn. 371(b) of International Application Serial No. PCT/GB2016/050408 filed Feb. 18, 2016, which claims the right of priority and benefit under 35 U.S.C. .sctn..sctn. 119 & 365 of GB
Najkompletnija baza ljekovitog bilja potpomognuta znanošću
- Radi na 55 jezika
- Biljni lijekovi potpomognuti znanošću
- Prepoznavanje bilja slikom
- Interaktivna GPS karta - označite bilje na mjestu (uskoro)
- Pročitajte znanstvene publikacije povezane s vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima
